NCT02581540

Brief Summary

The aim of this observational study is twofold. The primary hypothesis being tested is that initial(first) high sensitivity Tn \<5ng/l (limit of detection) combined with an ECG with no ischaemic changes is superior as an accelerated diagnostic tool/strategy compared to TIMI score (\<2), GRACE \<75 and HEART score ≤ 3. (Hs tn T- Roche elecsys HS tn T) and also against HS troponin at the 99th percentile (\<15ng/l with nonischaemic changes)- again all scored with initial (first tn ) only. The second aim is to directly compare the three established methods of risk stratifying patients (predicting risk in suspected heart attacks) namely, the Global Registry of Acute Coronary Events (GRACE), Thrombolysis in Myocardial Infarction (TIMI) and HEART score in the era of high sensitivity troponins performs best.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,054

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2011

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 21, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

September 9, 2021

Status Verified

August 1, 2016

Enrollment Period

5.1 years

First QC Date

July 20, 2015

Last Update Submit

September 1, 2021

Conditions

Keywords

TroponinHigh Sensitivity Troponin TMACErisk stratificationsuspected cardiac chest painAcute Coronary SyndromeGRACETIMIHEART

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with major adverse cardiac events(MACE)- death, non-fatal myocardial infarction and emergency revascularisation at 1 year

    To compare the observed versus predicted incidence of major adverse cardiovascular events (MACE) amongst the three methods of risk stratifications (GRACE, TIMI, HEART) at 1 year in order to determine the most effective risk score

    12 months observational period from recruitment date

Secondary Outcomes (1)

  • Number of Participants with major adverse cardiac events(MACE)- death, non-fatal myocardial infarction and emergency revascularisation ; in patients with a normal ECG/initial Troponin

    12 months observational period from recruitment date

Study Arms (1)

Suspected Cardiac Chest Pain

This cohort is observed for the incidence of MACE (death, non-fatal myocardial infarction and emergency revascularisation)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients presenting to the emergency department at a single large teaching hospital- Aintree University Hospital, Merseyside between June 2011 and November 2011 with suspected cardiac chest pain

You may qualify if:

  • All patients aged \>18 years presenting to the emergency department at Aintree University Hospital,Merseyside between June-November 2011 with suspected cardiac chest pain

You may not qualify if:

  • The presence of a definitive non-ischaemic cause for chest pain, trauma-related chest pain, cardiac arrest on arrival to the ED.
  • Patients without HS troponin T which indicates no suspicion of a cardiac cause of chest pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Khand A, Frost F, Grainger R, Fisher M, Chew P, Mullen L, Patel B, Obeidat M, Albouaini K, Dodd J. Identification of high-risk non-ST elevation myocardial infarction at presentation to emergency department. A prospective observational cohort study in North West England. BMJ Open. 2020 Jun 8;10(6):e030128. doi: 10.1136/bmjopen-2019-030128.

MeSH Terms

Conditions

Acute Coronary SyndromeAngina PectorisCardiovascular DiseasesChest PainHeart DiseasesMyocardial IschemiaMyocardial InfarctionAngina, Unstable

Condition Hierarchy (Ancestors)

Vascular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsInfarctionIschemiaPathologic ProcessesNecrosis

Study Officials

  • Aleem Khand, MbChB,MRCP

    Aintree University Hospital NHS Trust, Liverpool Heart and Chest Hospital NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2015

First Posted

October 21, 2015

Study Start

June 1, 2011

Primary Completion

July 1, 2016

Study Completion

July 1, 2016

Last Updated

September 9, 2021

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will not share

All data anonymised and will be analysed accordingly. Results of the study will be published once analysis completed